What are the indications, dosing regimens, contraindications, and side effects of levonorgestrel for emergency contraception and routine hormonal birth control?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Levonorgestrel: Indications, Dosing, Contraindications, and Side Effects

Emergency Contraception Indications

Levonorgestrel 1.5 mg is the first-line oral emergency contraceptive for patients presenting within 72 hours of unprotected intercourse, and should be offered to any patient requesting it regardless of perceived pregnancy risk. 1

  • The CDC recommends providing emergency contraception even after low-risk intercourse (e.g., condom use without ejaculation), prioritizing patient autonomy over theoretical risk calculations. 1
  • Emergency contraception is appropriate even when patients are already using combined oral contraceptives or depot medroxyprogesterone acetate if unprotected intercourse or contraceptive failure has occurred. 2
  • Specific scenarios warranting levonorgestrel include: missed or late doses of regular contraception during the first week of a pill pack, or DMPA injection delayed ≥2 weeks (≥15 weeks after previous injection). 2

Dosing Regimens for Emergency Contraception

The standard dose is levonorgestrel 1.5 mg as a single dose, which can be given as one 1.5 mg tablet or two 0.75 mg tablets taken simultaneously. 1

  • Maximum effectiveness occurs when administered as soon as possible within 72 hours of intercourse, with efficacy declining markedly after this window. 1
  • The medication remains usable up to 120 hours (5 days) after intercourse, though effectiveness is substantially reduced at 96-120 hours compared to earlier administration. 1
  • The two-dose regimen (0.75 mg taken twice, 12 hours apart) is FDA-approved but offers no advantage over single-dose administration; the second dose can be taken 12-24 hours after the first without compromising efficacy. 3

Clinical Algorithm for Emergency Contraception Selection

Within 72 hours for normal-weight patients (≤165 lbs): Levonorgestrel 1.5 mg single dose is appropriate, though ulipristal acetate may have a slight efficacy advantage. 1

Within 72 hours for patients >165 lbs: Ulipristal acetate 30 mg is preferred over levonorgestrel due to reduced efficacy of levonorgestrel in obese women regardless of dose. 1, 2

Between 72-120 hours: Ulipristal acetate 30 mg is significantly more effective than levonorgestrel, which shows sharply declining efficacy after 72 hours with substantially higher pregnancy rates at 4-5 days. 1, 2

Highest efficacy at any timepoint: The copper IUD inserted within 5 days provides <1% failure rate and offers ongoing contraception, making it the most effective emergency contraception method regardless of timing or patient weight. 1, 2

Mechanism of Action

Levonorgestrel works primarily by delaying or inhibiting ovulation when given before the preovulatory LH surge begins. 4, 5

  • Once LH has started to increase, levonorgestrel cannot prevent ovulation and does not prevent fertilization. 4
  • The medication has no effect on endometrial development, fallopian tube function, or blastocyst implantation—it does not act as an abortifacient. 4
  • The biological mechanism has inherent limits that cannot be overcome by increasing the dose, which is why standard 1.5 mg dosing is maintained. 1

Post-Emergency Contraception Management

After levonorgestrel use: Resume or start regular contraception immediately, but use barrier method or abstain for 7 consecutive days after restarting hormonal contraception. 1, 2

After ulipristal acetate use: Start any contraceptive method immediately, but barrier contraception or abstinence is mandatory for 14 consecutive days (or until next menses, whichever occurs first). 1, 2

  • Perform a pregnancy test if withdrawal bleeding does not occur within 3 weeks after levonorgestrel administration. 1, 6
  • After ulipristal acetate, obtain a pregnancy test if no withdrawal bleed occurs within 3 weeks. 1
  • Patients already on combined oral contraceptives should continue their pill pack as scheduled after emergency contraception use. 2

Contraindications and Limitations

Known or suspected pregnancy is the primary contraindication, though levonorgestrel will not harm an existing pregnancy. 7

  • Prior use of combined hormonal contraceptives does not contraindicate emergency contraception provision. 1
  • Existing hormonal contraception (COC or DMPA) does not interfere with emergency contraception effectiveness. 2
  • Levonorgestrel should not be used as an ongoing contraceptive method—it is a backup option, not a substitute for regular contraception. 7

Side Effects and Adverse Events

Common adverse effects (not serious): Nausea, vomiting, headache, breast tenderness, and transient alteration of menstrual bleeding pattern. 7, 8

Uncommon adverse reactions: Anorexia, exanthema, chloasma, weight gain. 8

Rare serious adverse events reported: Ectopic pregnancy (when treatment fails), convulsion, stroke, anaphylaxis, ovarian cyst rupture, febrile neutropenia, serious infections. 8

  • The prevalence of adverse events is not statistically different between the 0.75 mg two-dose regimen and the 1.5 mg single-dose regimen. 8
  • Tolerance is similar to or better than other oral emergency contraceptives. 7
  • It is unknown whether levonorgestrel increases the risk of ectopic pregnancy when treatment fails, though ectopic pregnancy has been reported. 7, 8

Important Clinical Caveats

Timing is critical: Counsel patients that efficacy diminishes with time, reinforcing the importance of prompt administration within 72 hours. 1

Weight considerations: In obese women, levonorgestrel efficacy is reduced regardless of dose; ulipristal acetate or copper IUD should be strongly considered. 1, 6

Pre-ejaculate concerns: While condom use without ejaculation carries very low pregnancy risk, pre-ejaculate can theoretically contain sperm, justifying emergency contraception provision when patients request it. 1

Repeated use: Data regarding adverse reactions from repeated levonorgestrel use are scarce, and further studies are needed to ensure safety with multiple uses. 8

References

Related Questions

Is it okay to give an additional levonorgestrel (LN) 1.5mg pill after a combination of levonorgestrel (LN) 1.5mg and ethinyl estradiol (EE) has already been administered for emergency contraception?
What is the most effective emergency contraception for an otherwise healthy 18‑year‑old woman who had a condom rupture at peak ovulation and took a single dose of levonorgestrel (Plan B) one hour later?
What are the options for emergency contraception after unprotected sex?
Is an inpatient visit required to obtain Plan B (levonorgestrel)?
Can morning-after pills (levonorgestrel) prevent implantation of a fertilized egg if ovulation has already occurred?
For an adult with mild‑to‑moderate internal or external hemorrhoids and no allergy or contraindication to topical steroids, how should I use a topical hemorrhoid cream (e.g., Preparation H® Hydrocortisone Cream with lidocaine or pramoxine) – what concentration, application frequency, and maximum duration – and when should I consider second‑line therapies?
In an adult with mildly elevated aspartate aminotransferase (AST) of 56 U/L and alanine aminotransferase (ALT) of 66 U/L, what is the appropriate initial evaluation and management?
What is the appropriate management for a patient with hypercholesterolemia and markedly elevated low‑density lipoprotein cholesterol?
Can a chronic hemodialysis patient with a bacterial pleural effusion, previously treated with Bactrim (trimethoprim‑sulfamethoxazole) for a wound infection, be started on levofloxacin (Levaquin)?
What is the appropriate Bactrim (trimethoprim‑sulfamethoxazole) dosing regimen for a urinary tract infection in a patient with end‑stage renal disease on dialysis, assuming the organism is susceptible and there is no sulfa allergy?
What antibiotic regimen is recommended for acute diverticulitis in a patient with a documented penicillin allergy to provide gram‑negative and anaerobic coverage while avoiding β‑lactam agents?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.